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Abstract
Background: Transverse myelitis, subarachnoid hemorrhage, and nephropathy are established but rare
complications of hepatitis B virus infection that can potentially be triggered by an antibody-mediated vasculitis as a
result of a viral infection. The following is a case report detailing a patient presenting with all three of the above
presentations who is cytoplasmic antineutrophil cytoplasmic antibody-positive and a chronic carrier of hepatitis B.
Case presentation: A 33-year-old Nepalese man presented to our hospital with headache, swelling of his body,
paraplegia, and back pain that developed over a period of 10 days. Laboratory studies showed proteinuria and
elevated levels of serum urea and creatinine. Viral serology was suggestive of chronic inactive hepatitis B carrier
state. A computed tomography scan of his head revealed features suggestive of subarachnoid hemorrhage.
Magnetic resonance imaging of his dorsal spine showed diffuse T2 high signal intensity within his spinal cord
extending from second to 12th thoracic vertebral level which was suggestive of transverse myelitis. The origin of
these symptoms was attributed to immune complex-mediated vasculitis after serum analysis for cytoplasmic
antineutrophil cytoplasmic antibody came out positive. He was managed with steroids administered orally and
intravenously and entecavir administered orally.
Conclusion: This case highlights the possibility of a hepatitis B virus-induced vasculitis as the cause of
subarachnoid hemorrhage, transverse myelitis, and nephropathy.
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Background
Hepatitis B is an established cause of chronic liver
disease and hepatocellular carcinoma [1]. It is associated
with several extrahepatic manifestations including but
not limited to serum sickness, polyarteritis nodosa,
urticaria, leukocytoclastic vasculitis, and essential mixed
cryoglobulinemia. In addition to these manifestations,
hepatitis B virus (HBV) has also been documented to be
involved in the etiopathogenesis of antineutrophil
cytoplasmic antibodies (ANCA)-positive vasculitis [2].
HBV-induced vasculitis is an uncommon but important
cause of subarachnoid hemorrhage (SAH), transverse
myelitis, and nephropathy. Common causes of SAH include
aneurysm, arteriovenous malformations, anticoagulation,
and brain tumors, possibly followed by vasculitis [3].
Transverse myelitis, on the other hand, is an inflammation
of the spinal cord manifesting as weakness, sensory loss,
and autonomic dysfunction. Although a large proportion of
cases of transverse myelitis are idiopathic in origin, quite a
few cases have been attributed to vasculitis in addition to
conditions like infectious, parainfectious, and systemic
autoimmune diseases, and paraneoplastic and ischemic
disease [4]. HBV has also been widely recognized to be
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associated with a wide variety of glomerulonephritis, not-
ably membranous nephropathy [5]. Other causes include
immunological disorders, inherited diseases, metabolic dis-
eases, and deposition disorder [6].
We report an interesting case of SAH, transverse mye-
litis, and nephrotic syndrome in a patient who is a
chronic carrier of hepatitis B.
Case presentation
A 33-year-old Nepalese man presented to our depart-
ment of neurology in a university hospital for evaluation
of an acute-onset flaccid paraplegia in the background of
a 10-day history of headache and puffiness of the face.
Ten days prior to his presentation to our hospital, he
had sudden onset, unilateral right-sided headache that
later became generalized. He developed facial puffiness
concomitant with headache that gradually progressed to
involve his lower limbs. This was associated with short-
ness of breath on exertion, but without cough, fever, and
decreased urinary output. For these complaints, he was
initially evaluated at a local medical center. During his stay
at the center, on his eighth day of admission, he developed
stiffness of the neck for which he underwent lumbar
puncture. The lumbar puncture yielded a bloody tap. He
was then referred to our center for further evaluation.
During his transfer from the local medical center to our
hospital, he developed a sudden onset weakness of both
lower limbs with loss of sensation. He presented with all of
these symptoms at our center 10 days after the onset of
headache. The loss of sensation gradually spread up to the
level of his xiphisternum. He also developed severe back
pain in his mid-thoracic region. He gave no history of
weakness or any sensory disturbances involving his upper
limbs. However, there was a history of both bowel and
urinary incontinence. There was no history of loss of
consciousness, altered sensorium, or seizures. He did not
have any ocular symptoms at presentation. There was no
evidence of a recent respiratory or gastrointestinal tract in-
fection prior to the development of lower limb weakness.
He had no history of alcohol intake or tobacco smoking.
There was also no history of chronic medical illness.
His higher mental functions and cranial nerves exam-
ination were normal. Visual acuity and fundal examin-
ation were also normal. Muscle strength was intact in
his upper limbs. Muscle tone was decreased in both
lower limbs. Power across all major muscle groups in his
lower limbs was 0/5. Deep tendon reflexes were absent
in his lower extremities. Bilateral plantar responses were
mute. A sensory examination revealed a sensory level at
approximately T4/T5.
Blood investigations showed: hemoglobin 12.1 gm/dl,
packed cell volume 36%, white blood cells 17190/mm3
(neutrophil 82%, lymphocytes 16%, eosinophils 1%), and
platelets 213,000/mm3. His renal function test was deranged:
urea 21 mmol/l and creatinine 185 μmol/l. Urine routine
evaluation showed: white blood cells 1 to 2 cells per high
power field, red blood cells 8 to 10 cells per high power field,
and albumin 3+ without any casts. Tests for human
immunodeficiency virus (HIV) and hepatitis C virus (HCV)
were negative. Serology was positive for hepatitis B surface
antigen (HBsAg) and hepatitis B e antibodies (anti-HBe)
while hepatitis B e antigen (HBeAg) and hepatitis B core
IgM antibodies (anti-HBc IgM) were negative. His hepatitis
B viral load was less than 2000 IU/ml. Venereal Disease Re-
search Laboratory (VDRL) test and rapid plasma reagin test
were negative. Serology was negative for cytomegalovirus
(CMV), varicella zoster virus (VZV), and herpes simplex
virus (HSV). His 24-hour urinary total protein was 3.9
grams per day, suggestive of nephrotic range proteinuria.
Cerebrospinal fluid (CSF) analysis revealed pleocytosis
with elevated protein and normal glucose: total count
1300 with 70% polymorphs and 30% monomorphs, pro-
tein 380 mg/dl, and sugar 5.3 mmol/l. The red blood
cells count in CSF was 12,500/mm3 and the opening
pressure was 26 cm of water. Microscopy with gram
stain and acid-fast bacilli stain followed by culture did
not reveal any organism. CSF VDRL was also negative.
A computed tomography (CT) scan of his head revealed
linear hyperdense areas in his ambient and suprasellar
cisterns which was suggestive of SAH (Fig. 1). Magnetic
resonance imaging (MRI) of his dorsal spine showed
diffuse T2 high signal intensity within his spinal cord
extending from second to 12th thoracic vertebral level
which was suggestive of transverse myelitis (Fig. 2). A CT
cerebral and spinal angiogram did not reveal any abnor-
malities. However, an MRI of his brain was not done.
Serological evaluations for antinuclear antibodies and
anti-double stranded-deoxyribonucleic acid antibodies
were negative and his serum angiotensin-converting en-
zyme (ACE) level was normal. Immunofluorescent assay
showed perinuclear-ANCA (p-ANCA) within range but
cytoplasmic-ANCA (c-ANCA) was positive with end-
point titer over 1:20. In the light of positive serological
tests for HBV and c-ANCA that pointed toward the vas-
culitic origin of myelitis, a further test for neuromyelitis
optica (NMO) was not carried out.
The final impression was that of a SAH with acute
transverse myelitis and with nephrotic syndrome in a pa-
tient who is a chronic carrier of hepatitis B. He was started
on entecavir administered orally for hepatitis B infection.
He was treated for myelitis with methylprednisolone
administered intravenously (1 gram per day) for 3 days
followed by a short course of prednisolone administered
orally. During the course of his stay at our hospital, his
sensory symptoms improved but his motor symptoms did
not improve. Moreover, it was not economically feasible
for him to remain in our hospital any longer and, hence,
he was discharged after 1 month of hospital stay. He and
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his family members were counselled about rehabilitative
care to prevent secondary complications of prolonged im-
mobility. He came for regular follow-up in our neurology
clinic for the next 3 months during which his condition
remained the same with no improvement in motor func-
tion. After 3 months, he was lost to follow-up.
Discussion
This case report describes an atypical case of SAH, trans-
verse myelitis and nephrotic syndrome in an HBsAg-carrier.
Infectious agents can be the underlying cause of several
vasculitides. Various viruses have been found to be re-
sponsible for vasculitis: HCV, HBV, HIV, CMV, VZV, HSV,
and human T-cell lymphotropic virus type 1 (HTLV-1) to
name a few of them [7]. Extrahepatic manifestations due
to HBV infection may be attributed to deposition of
immune complexes. Immune complexes promote aggre-
gation of platelets and activation of Hageman factor that
result in inflammation and microthrombi formation.
Deposition of these complexes in small arteries and
glomeruli may be responsible for clinical presentations of
vasculitis and nephritis [8]. In the literature, a causal
relationship has only been firmly established in a few
instances of vasculitis, such as chronic HBV infection and
polyarteritis nodosa [9].
Immune complex-mediated vasculitis is also associated
with ANCA positivity. A positive association has been dem-
onstrated between spinal cord lesion and ANCA; especially
between longitudinally extensive transverse myelitis and
ANCA. A significant number of patients with transverse
myelitis have been found to be p-ANCA and c-ANCA
positive, albeit these cases were idiopathic [10]. Moreover,
borderline positive c-ANCA was significantly higher in
chronic hepatitis B group as compared to control [2].
Fig. 1 Computed tomography image of the head; the axial section of
the brain is shown. The image shows linear hyperdense areas in the
ambient and suprasellar cisterns suggestive of subarachnoid bleeding
Fig. 2 Magnetic resonance image of thoracic spine; sagittal view of
thoracic segment of the spinal cord is shown. The image shows
diffuse T2 high signal intensity within the spinal cord extending
from second to 12th thoracic vertebral level
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Vasculitis associated with HBV infection has been
reported, although rarely, to be responsible for central and
peripheral nervous system lesions including myelitis [11]. It
may play an important role in the pathogenesis of
transverse myelitis, indirectly by triggering an immune re-
action that damages neural tissue. This immunological
phenomenon is further supported by the observation that
the preceding infection fully subsides before the onset of
symptoms and no infectious agent can be detected in the
central nervous system. Cases of transverse myelitis subse-
quent to vaccination have also been reported [4]. The same
immunological phenomenon secondary to HBV infection
might be the cause of SAH in our patient. Even though
aneurysms are the most common cause of non-traumatic
SAH, vasculitis together with arteriovenous malformations,
anticoagulation, and brain tumor should also be considered
to be other important causes of SAH [3].
Besides neurological involvement, membranous nephrop-
athy is one of the widely recognized forms of glomerulo-
nephritis associated with HBV infection [5]. Subendothelial
and mesangial immune deposits may cause capillary and
mesangial injuries with subsequent inflammation and
nephropathy [12]. The same pathogenesis may be used to
explain the nephrotic-range proteinuria and renal impair-
ment in our patient.
In our case, the patient did not have any clinical features
suggestive of optic neuritis. Although myelitis alone is
sufficient to make a diagnosis of NMO, the seropositivity
for HBV and c-ANCA pointed toward the vasculitic origin
of transverse myelitis and gave a plausible explanation for
the occurrence of myelitis. Moreover, the economic situ-
ation of our patient and the cost of the test had to be
taken into account in this case and, for the same reason, it
would not have been cost effective or helpful. Besides,
MRI of the brain was also not done in our patient. A CT
scan of his head showed typical SAH and the MRI find-
ings of his dorsal spine combined with SAH could be ex-
plained by HBsAg-induced vasculitis. In the light of these
results, an MRI of his brain was also deemed unnecessary.
Conclusions
This case report highlights the possibility of HBV infec-
tion as a cause of vasculitis. Immune complex-mediated
vasculitis triggered by chronic hepatitis B infection might
result in myelitis along with SAH and nephropathy. Physi-
cians should not overlook the possibility of neurological
and renal symptoms being triggered by HBV infection in a
patient who is a chronic carrier.
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